LINNIK MATTHEW D 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Dec 15, 2005
Insider Transaction Report
Form 4
LINNIK MATTHEW D
CSO & Exec VP of Research
Transactions
- Award
Common Stock
2005-12-14+101,827→ 108,324 total
Footnotes (1)
- [F1]Restricted stock grant pursuant to that certain Retention Agreement, dated October 6, 2005.